Lower urinary tract symptoms (LUTS) are very common in men, with incidence increasing with age.
Several clinical practice guidelines are available as decision-making aids for men with LUTS and the recommendations are based on the presumed etiology of the symptoms (due to obstruction, overactive bladder or a combination of the two). This review presents the various pharmacologic treatment options and summarizes key clinical trial data supporting their use.
Written by:
Roehrborn C. Are you the author?
Professor and Chair, Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas.
Reference: Can Urol Assoc J. 2012 Oct;6(5 Suppl 2):S130-2.
doi: 10.5489/cuaj.12231
PubMed Abstract
PMID: 23092776
